Diversity of DNA topoisomerases I and inhibitors
- 5 March 1998
- Vol. 80 (3), 255-270
- https://doi.org/10.1016/s0300-9084(98)80008-4
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Cell cycle effects of the novel topoisomerase I inhibitor NU/ICRF 505 in a panel of chinese hamster ovary cell linesEuropean Journal Of Cancer, 1997
- CPT-11 (Irinotecan) in the treatment of colorectal cancerEuropean Journal Of Cancer, 1995
- A model for topoisomerase I-mediated insertions and deletions with duplex DNA substrates containing branches, nicks, and gapsBiochemistry, 1995
- Infant Leukemia, Topoisomerase II Inhibitors, and the MLL GeneJNCI Journal of the National Cancer Institute, 1994
- Structure-mutagenicity relationships in series of 11H-indolo[3,2-c]quinoline-1,4-diones, tetrahydro-11H-indolo[3,2-c]quinoline-1,4-diones and 11H-pyrido[3′,4′:4,5]pyrrolo[3,2-c]quinoline-1,4-diones with leukemia cytotoxic properties. Relations with topoisomerase I inhibiting propertiesMutation Research, 1994
- Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal location of the geneGene, 1993
- A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal ringsCell, 1989
- Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and IICell, 1988
- Purification and characterization of a type I DNA topoisomerase from calf thymus mitochondriaBiochemistry, 1987
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966